Selective Inhibition of JAK1 Primes STAT5-Driven Human Leukemia Cells for ATRA-Induced Differentiation
Haley E. Ramsey(Vanderbilt University Medical Center), Michael R. Savona(Vanderbilt University), Jing Zou, Sandra S. Zinkel(Vanderbilt University), Kristy R. Stengel(Albert Einstein College of Medicine), Alexander L. R. Lubbock(Institute of Genetics and Cancer), Jonathan M. Irish(Vanderbilt University), James C. Pino(Pacific Northwest National Laboratory), Maria P. Arrate(Vanderbilt University), Agnieszka E. Gorska(Vanderbilt University), Melissa A. Fischer(University of Massachusetts Chan Medical School), Caroline E. Roe(Vanderbilt University), Merrida Childress(Vanderbilt University), Scott W. Hiebert(Vanderbilt University), Londa Fuller(Vanderbilt University), Carlos F. Lopez(Vanderbilt University), Matthew T. Villaume(Vanderbilt University), Matthew C. Stubbs(Incyte (United States)), Gretchen Johnston(Vanderbilt University), P. Brent Ferrell(Vanderbilt University Medical Center)
Cited by 3
Related Papers
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k
Abrogation of TGFβ Signaling in Mammary Carcinomas Recruits Gr-1+CD11b+ Myeloid Cells that Promote Metastasis
|Cancer Cell|2008|917
Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes
|Nature Medicine|2020|633
The interaction of RB with E2F coincides with an inhibition of the transcriptional activity of E2F.
|Genes & Development|1992|592